▶주메뉴 바로가기

▶본문 바로가기

The Korea Herald
검색폼

THE INVESTOR
March 29, 2024

Bio

Nature Cell CEO buys W198m company stocks

  • PUBLISHED :March 27, 2017 - 17:21
  • UPDATED :March 27, 2017 - 17:21
  • 폰트작게
  • 폰트크게
  • facebook
  • sms
  • print

[THE INVESTOR] South Korean biotechnology firm Nature Cell said March 27 its chief executive bought company’s shares worth 198 million won (US$178,500) in a bid to stabilize its sliding stock price.

With the purchase of 45,600 shares, Nature Cell CEO Rah Jeong-chan now holds a 0.32 percent stake in the company. While the amount is insignificant, shares held by Rah and his affiliated people stand at 13.3 million, accounting for 26.19 percent of the total. 




The move comes as the stock price of the company has dropped over 20 percent in the past two months due to geopolitical risks including South Korea’s decision to deploy US-based THAAD defense system in the country which has faced fierce protest from China.

Including Nature Cell, other Korean cosmetics companies, heavily relying on exports to China, saw their stock plunging as investors worried that the political event could take a toll on their business.

Recently, Nature Cell started to sell its dermal mask Dr.Jucre in Chongqing, China.

“Despite favorable events including the export of Dr.Jucre to China and the resumption of US clinical trials of our stem cell drug for Alzheimer’s disease treatment, the stock price has been undervalued,” an official at the firm said.

The shares rose 0.46 percent to close at 4,400 won.

By Park Han-na (hnpark@heraldcorp.com)

EDITOR'S PICKS